A recently completed double blind, placebo controlled human clinical trial showed significant results of Cynatine HNS’s ability to support healthy hair, nails and skin. The clinical study involved 50 women and looked at the ability of Cynatine HNS, along with B vitamins and minerals, to improve various metrics of internal beauty. For hair it focused on reduction in hair loss from everyday activities as well as the ability to improve the structure and appearance of hair. For skin it looked at the ability to improve skin moisture and elasticity as well as reduce wrinkles and improve the structure of skin. For nails it measured the health and strength of the nails and their tendency to break.
“The results of this study were excellent as it achieved statistical significance at all primary endpoints. This study clearly establishes Cynatine HNS as a leader in the cosmeceutical ingredient space and gives validation to the entire concept of beauty from within,” stated Robert H. Veghte, General Manager of Roxlor, “With this study in hand, we can clearly say that Cynatine HNS is the ingredient of choice for the cosmeceutical market.”
Roxlor is based out of Wilmington, DE and specializes in the manufacture and distribution of innovative branded ingredients for various categories in the nutraceutical and cosmeceutical markets. Other ingredients marketed by Roxlor include Cynatine FLX (improve inflammation and joints resilience), EnzyBoost (improved digestion and systemic enzyme complex), Immunel (improved immune system), Tegricel (helps regenerated intestinal and gastric mucosa and provide allergy relief). More information at roxlor.com.